This topic contains a solution. Click here to go to the answer

Author Question: The fear of not being able to perform during sexual behavior is known as ____. a. preoccupation ... (Read 38 times)

nmorano1

  • Hero Member
  • *****
  • Posts: 598
The fear of not being able to perform during sexual behavior is known as ____.
 
  a. preoccupation c. shifts in attention
  b. distractions d. performance fears

Question 2

When trial judges were asked to take the Cognitive Reflection Test, researchers found that the judges used
 
  A. intuitive processes.
  B. deliberative processes.
  C. distributive processes.
  D. both A and B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mammy1697

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

D

Answer to Question 2

D




nmorano1

  • Member
  • Posts: 598
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


Liddy

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library